Calley Dunn, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1342 County Road 94, New Albany, MS 38652 Phone: 662-202-7277 |
James Bailey, CRNA, DNP Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-7631 |
Mr. Gary H Chandler, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-2370 |
Mrs. Cheryl A Sanders, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-2370 |
Mr. Christopher Alan Henthorne, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-2370 |
Mrs. Summer Audra Palmer, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 200 Hwy 30 W, New Albany, MS 38652 Phone: 662-538-2370 |
News Archive
Generic forms of a biologic drug used to treat rheumatoid arthritis, inflammatory bowel disease and psoriasis appear to be as safe and effective as their brand-name counterparts, a new Johns Hopkins Bloomberg School of Public Health analysis suggests.
In a paper published today in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute, part of University Health Network in Toronto, have made a discovery that could lead to new treatments for axial spondyloarthritis (SpA), a painful and debilitating form of arthritis which affects 1-2% of Canadians and causes inflammation in the spine, joints, eyes, gut and skin.
The New York Times' "India Ink" blog interviews USAID Administrator Rajiv Shah "on his recent trip to Mumbai about transformations in the development sector, the function of the private sector in development work and the aid agency's new programs and partnerships aimed at reducing preventable child deaths."
The stem cell transplant regimen that was commonly used in the United States to treat advanced neuroblastoma in children appears to be more toxic than the equally effective regimen employed in Europe and Egypt, according to a new study to be presented at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami April 24-27.
› Verified 7 days ago